Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.920
+0.030 (0.61%)
At close: Aug 26, 2026, 4:00 PM EDT
4.920
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:10 PM EDT
Evolent Health Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Evolent Health stock has a consensus rating of "Buy" and an average price target of $5.77. The average 1-year stock price forecast is 17.28% higher than the current stock price, while the lowest is $3.00 (-39.02%) and the highest is $8.00 (+62.60%).
Price Target: $5.77 (+17.28%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Evolent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 8 | 6 | 8 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 3 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 15 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $5 → $6 | Buy | Reiterates | $5 → $6 | +21.95% | Aug 18, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $5 → $6 | Buy | Reiterates | $5 → $6 | +21.95% | Aug 17, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $7 → $6 | Hold | Reiterates | $7 → $6 | +21.95% | Aug 12, 2026 |
| Citi | Citi | Buy Upgrades $6.75 → $6 | Buy | Upgrades | $6.75 → $6 | +21.95% | Aug 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +21.95% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
2.64B
from 1.88B
Increased by 40.50%
Revenue Next Year
3.30B
from 2.64B
Increased by 25.10%
EPS This Year
0.20
from 0.09
Increased by 121.83%
EPS Next Year
0.39
from 0.20
Increased by 95.84%
EPS and Forward PE are based on non-GAAP adjusted numbers.